Evidence map›Paper›PMID 41426175›Full record

ArticleSouth Asian journal of cancer2025

Comparative Analysis of Postoperative Radiotherapy Dose Escalation in Oral Cavity Cancer Patients with Positive Margins: A Propensity Score-Matched Study.

Rashmi Sarawagi, Aravind Padmanabhan, Raju Prajapati, Manish Gupta, Saikat Das, Vipin Kharade, Arnav Tiwari, B Srinivas Reddy, Neelesh Shrivastava, Rajesh Pasricha

Abstract read
In one paragraph

Article in South Asian journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rashmi SarawagiDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Aravind PadmanabhanDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Raju PrajapatiDepartment of Radiation Oncology, Sukh Sagar Medical College and Hospital, Jabalpur, Madhya Pradesh, India.
Manish GuptaDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Saikat DasDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Vipin KharadeDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Arnav TiwariDepartment of Radiation Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
B Srinivas ReddyDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Neelesh ShrivastavaDepartment of Surgical Oncology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Rajesh PasrichaDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to determine the impact of postoperative (PO) radiotherapy (RT) dose escalation in oral cavity squamous cell carcinoma (OCSCC) patients with positive margin (PM) in terms of local control (LC), duration of RT interruption, and toxicity in a tertiary care center. Materials and Methods: Patients with OCSCC who were candidates for adjuvant RT were categorized into PM and negative margin (NM) arms depending on the margin status as per the histopathology report retrospectively. PM and NM patients received a total dose of 66 Gy to the site of the PM and 60 Gy for the NM. LC, acute and chronic toxicities, and duration of RT interruption were evaluated. Results: A total of 56 patients were included in the study, of whom 39 had NM and 17 had PM. After propensity score matching, 11 patients were matched in each arm. The mean duration of RT treatment in the PM and NM arms were 49.5 days (standard deviation [SD] = 5.4) and 50.7 days (SD = 10.15) ( Conclusion: Dose escalation to 66 Gy for PM during adjuvant RT for PO OCSCC can be used as an alternative strategy to reresection, especially in patients who have poor performance status, who have negative consent for surgery, and who have more than one adverse prognostic factor with comparable LC and toxicity as in the NM. However, further prospective studies are needed to establish its role as an alternative, which is highly unlikely in modern oncology practice, as PM patients are rarely seen in clinics currently with good surgical oncology practices.

Indexed as

negative marginoral cavity squamous cell carcinomapositive marginpostoperativeradiotherapy

Identifiers

PMID41426175
PMCPMC12714462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.